staurosporine has been researched along with Mastocytosis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Begna, K; Elliott, MA; Farrukh, F; Gangat, N; Hook, CC; Litzow, MR; Pardanani, A; Shah, MV; Tefferi, A | 1 |
| Abdelmagid, MG; Al-Kali, A; Begna, KH; Farrukh, F; Gangat, N; Larsen, JT; Litzow, MR; Pardanani, A; Reichard, KK; Sher, T; Singh, A; Tefferi, A | 1 |
| Akin, C; Arock, M; Degenfeld-Schonburg, L; Galli, SJ; Gotlib, J; Hartmann, K; Horny, HP; Metcalfe, DD; Reiter, A; Smiljkovic, D; Sotlar, K; Sperr, WR; Triggiani, M; Valent, P | 1 |
| Bednarski, JJ; Carter, MC; Nieman, E; Polk, B; Voelker, D | 1 |
| Albano, F; Bavaro, L; Calogero, R; Cavo, M; Ciceri, F; De Benedittis, C; Delledonne, M; Elena, C; Fontana, MC; Gangemi, D; Guadagnuolo, V; Haferlach, T; Mancini, M; Manfrini, M; Martinelli, G; Meggendorfer, M; Merante, S; Morigi, F; Padella, A; Pagano, L; Papayannidis, C; Poletti, G; Riccioni, L; Rondoni, M; Savini, P; Scaffidi, L; Soverini, S; Specchia, G; Tosi, P; Valent, P; Zago, E; Zanotti, R | 1 |
| Gotlib, J | 1 |
| Castells, MC | 1 |
| Barbui, T; Bose, P; Chen, CC; Deininger, MW; Gotlib, J; Kiladjian, JJ; Koschmieder, S; Kucine, N; Mughal, TI; Pemmaraju, N; Radich, JP; Rampal, R; Saglio, G; Valent, P; Van Etten, RA; Verstovsek, S | 1 |
| Bennett, KL; Blatt, K; Dutreix, C; Eisenwort, G; Gridling, M; Hadzijusufovic, E; Hoermann, G; Manley, PW; Peter, B; Radia, D; Reiter, A; Rix, U; Roesel, J; Schwaab, J; Stefanzl, G; Superti-Furga, G; Valent, P; Winter, GE | 1 |
| Bauer, K; Cerny-Reiterer, S; Hadzijusufovic, E; Hoermann, G; Pirker, A; Reifinger, M; Valent, P; Willmann, M | 1 |
1 review(s) available for staurosporine and Mastocytosis
| Article | Year |
|---|---|
Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms.
Topics: Aging; Animals; Congresses as Topic; DNA Mutational Analysis; Humans; Inflammation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mastocytosis; Medical Oncology; Mice; Mutation; Myeloproliferative Disorders; Prognosis; Societies, Medical; Staurosporine; Translational Research, Biomedical; United States | 2019 |
9 other study(ies) available for staurosporine and Mastocytosis
| Article | Year |
|---|---|
Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experience.
Topics: Humans; Mast Cells; Mastocytosis; Mastocytosis, Systemic; Retrospective Studies; Staurosporine | 2022 |
Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive cases.
Topics: Aged; Female; Humans; Leukemia, Mast-Cell; Male; Mastocytosis; Mastocytosis, Systemic; Proto-Oncogene Proteins c-kit; Retrospective Studies; Staurosporine | 2022 |
Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?
Topics: Humans; Mast Cell Activation Disorders; Mast Cells; Mastocytosis; Mastocytosis, Systemic; Proto-Oncogene Proteins c-kit; Staurosporine | 2022 |
Hematopoietic KIT D816Y mutation presenting as in utero aggressive systemic mastocytosis with response to midostaurin.
Topics: Humans; Mastocytosis; Mastocytosis, Systemic; Mutation; Staurosporine | 2023 |
SETD2 and histone H3 lysine 36 methylation deficiency in advanced systemic mastocytosis.
Topics: Adult; Aged; Apoptosis; Cell Line, Tumor; Female; Histone-Lysine N-Methyltransferase; Histones; Humans; K562 Cells; Lysine; Male; Mast Cells; Mastocytosis; Mastocytosis, Systemic; Methylation; Middle Aged; Mutation; Prognosis; Proteasome Endopeptidase Complex; Staurosporine | 2018 |
A molecular roadmap for midostaurin in mastocytosis.
Topics: Humans; Mastocytosis; Staurosporine | 2017 |
Mastocytosis: Moving the Field to Precision and Personalized Medicine.
Topics: Animals; Humans; Mast Cells; Mastocytosis; Precision Medicine; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Quality of Life; Staurosporine; Tryptases; Urticaria Pigmentosa | 2018 |
Target interaction profiling of midostaurin and its metabolites in neoplastic mast cells predicts distinct effects on activation and growth.
Topics: Adult; Aged; Basophils; Cell Line, Tumor; Cell Survival; Female; Histamine Release; Humans; Male; Mast Cells; Mastocytosis; Middle Aged; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-kit; Staurosporine | 2016 |
IL-4 downregulates expression of the target receptor CD30 in neoplastic canine mast cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Brentuximab Vedotin; Cell Line, Tumor; Cytokines; Dog Diseases; Dogs; Down-Regulation; Drug Synergism; Female; Immunoconjugates; Interleukin-4; Ki-1 Antigen; Male; Mastocytosis; Piperidines; Pyridines; Staurosporine; Thiazoles | 2017 |